FIELD: pharmacology. SUBSTANCE: composition has therapeutically active quantity of erythromycin and special purpose admixtures in % from erythromycin mass like starch 40.95-71.33, polyvinyl pyrrolidone3.53-4.77, Twin-80 2.78-3.84 and a stearate salt 1.39-1.95. Nucleus tablet is coated with film-building shell manufactured from a mixture of acetylphthalyl cellulose, castor oil and titanium dioxide. Method involves applying humid granulation followed with coating nucleus tablet with filmbuilding composition. Application time is no less than 2 years. EFFECT: easy release of active ingredient; high level of bioavailability. 8 cl, 1 tbl
